The Application Notebook
Tobacco Specific Nitrosamines (TSNA) are a group of carcinogens found only in tobacco products and are formed from nicotine and related alkaloids during the production and processing of tobacco and tobacco products (1). Due to their carcinogenic properties, efforts have been made to reduce TSNA levels in tobacco products. The project goal was to demonstrate a high throughput and sensitive method to monitor TSNA levels.
Tobacco Specific Nitrosamines (TSNA) are a group of carcinogens found only in tobacco products and are formed from nicotine and related alkaloids during the production and processing of tobacco and tobacco products (1). Due to their carcinogenic properties, efforts have been made to reduce TSNA levels in tobacco products. The project goal was to demonstrate a high throughput and sensitive method to monitor TSNA levels.
Conventional methods for TSNA analysis are based on gas chromatography with thermo energy analyzer (GC-TEA) (2,3,) or high performance liquid chromatography (HPLC) with various detection techniques, such as UV and mass spectrometry (MS) (4-6). This application note describes a robust and fast LC–MS-MS method for the determination of four TSNAs in tobacco cigarettes.
Figure 1
Chromatographic Conditions
Analytical Column: Acclaim® RSLC PA2 (5.0 × 2.1 mm, 2.2 μm)
Column Temperature: 60 °C
Injection Volume: 10 μL
Mobile Phase: 10% CH3CN in buffer (1 mM NH4OAc, pH adjusted to pH 8.0 by NH4OH)
Flow Rate: 0.50 mL/min
Detection: UV @ 230 nm TSQ Quantum Access™ SRM with H-ESI
Mass Spectrometric Conditions
See Figure 1.
The first SRM transition of each compound is used for quantification and the second SRM transition is used for confirmation.
NNN: N'-nitrosonornicotine, NAT: N'-nitrosoanatabine, NAB: N-nitrosoanabasine. NNK: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Figure 1 shows the four TSNAs retained and completely resolved within 3.5 min, with the minimum of the retention factors (K'NNN) being greater than four and minimum resolution (RsNAT) greater than two. Demonstrated retention factors ensure the chromatographic separation of analytes of interest from early eluted compounds, which minimizes the possibility of ionization suppression and eliminates cross contamination of SRM transitions between main analytes. The use of specific MS-MS detection allows the simplification of sample preparation, and the greater sensitivity ensures quantification confidence at low levels.
Since the analytical column was running under the very harsh conditions of high temperature and high pH mobile phase, method ruggedness was evaluated by repeated injections of standard solutions and tobacco extracts and was well maintained after more than 1000 injections.
A simple, sensitive, and specific method for the determination of tobacco specific nitrosamines is demonstrated and has been applied to the analysis of TSNAs in different cigarettes.
(1) Hecht, S. S.; Hoffmann, D. Carcinogenesis 1988, 9, 875–884.
(2) Adams, J. D.; Brunnemann, K. D.; Hoffmann, D. J.Chromatog.,A 1983, 256, 347–351.
(3) Krull, I. S.; Swartz, M.; Hilliard, R.; Xie, K. H.; Driscoll, J. N. J. Chromatog., A 1983, 260, 347–362.
(4) Wu, W.; Ashley, D. L.; Watson, C. H. Anal. Chem. 2003, 75, 4827–4832.
(5) Wagner, K. A.; Finkel, N. H.; Fossett, J. E.; Gillman, I. G. Anal. Chem. 2005, 77, 1001–1006.
(6) Wu, J.; Joza, P.; Sharifi, M.; Rickert, W. S.; Lauterbach, J. H. Anal. Chem. 2008, 80, 1341–1345.
TSQ Quantum Access is a trademark of Thermo Fisher Scientific. All other trademarks are the property of Dionex Corporation.
Dionex Corporation
1228 Titan Way, P.O. Box 3603, Sunnyvale, CA 94088-3603
tel. (408)737-0700, fax (408)730-9403
Website: www.dionex.com
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
GPCRs – The Biological Traffic Modulator: Chromatographic Analysis of Peptides in the GI Tract
January 20th 2025The G protein-coupled receptors (GPCR) are found throughout the entire body and have shown significance in the development of new therapeutic treatments. Isolation of seven classic GRPC peptides initiating in the GI tract highlights the benefits of using the polymer-based PRP-3, a reversed-phase resin. The covalent bonds found in the PRP-3 exhibit advantageous interactions between the biological π bonds found in the peptides and the available aromatic benzyl rings of the resin.